The peptide activates extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation in a dose-dependent manner, leading to nuclear translocation and activation of transcription factors including c-Fos, c-Jun, and early growth response-1 (Egr-1) that drive expression of genes involved in cell growth, migration, and angiogenesis
AOD-9604 targets obesity originally developed from a fragment of HGH, it is tailored to reduce adipose tissue mass and related metabolic conditions without affecting other bodily functions (5)
This combination of direct fat cell targeting, muscle preservation, metabolic selectivity, and favorable safety profile makes AOD-9604 a distinctive option among metabolic peptides and body composition interventions
+ What molecular formula and CAS number apply
Laboratory Safety Protocols Standard laboratory safety practices should always be followed when handling peptide reagents and other experimental compounds